• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

单分子成像显示配体调节 CXCR4 寡聚状态在活细胞中。

Single-Molecule Imaging Demonstrates Ligand Regulation of the Oligomeric Status of CXCR4 in Living Cells.

机构信息

State Key Laboratory of Heavy Oil Processing and Center for Bioengineering and Biotechnology, China University of Petroleum (East China) , Qingdao 266580, P. R. China.

出版信息

J Phys Chem B. 2017 Feb 23;121(7):1466-1474. doi: 10.1021/acs.jpcb.6b10969. Epub 2017 Feb 9.

DOI:10.1021/acs.jpcb.6b10969
PMID:28118546
Abstract

The role of dimerization and oligomerization of G-protein-coupled receptors in their signal transduction is highly controversial. Delineating this issue can greatly facilitate rational drug design. With single-molecule imaging, we show that chemokine receptor CXCR4 exists mainly as a monomer in normal mammalian living cells and forms dimers and higher-order oligomers at a high expression level, such as in cancer cells. Chemotaxis tests demonstrate that the signal transduction activity of CXCR4 does not depend only on its expression level, indicating a close relation with the oligomeric status of CXCR4. Moreover, binding ligands can effectively upregulate or downregulate the oligomeric level of CXCR4, which suggests that binding ligands may realize their pivotal roles by regulating the oligomeric status of CXCR4 rather than by simply inducing conformational changes.

摘要

G 蛋白偶联受体的二聚化和寡聚化在其信号转导中的作用存在很大争议。明确这个问题可以极大地促进合理的药物设计。通过单分子成像,我们表明趋化因子受体 CXCR4 在正常哺乳动物活细胞中主要以单体形式存在,并且在高表达水平下(如癌细胞中)形成二聚体和更高阶的寡聚体。趋化性测试表明,CXCR4 的信号转导活性不仅取决于其表达水平,这表明与 CXCR4 的寡聚状态密切相关。此外,结合配体可以有效地上调或下调 CXCR4 的寡聚水平,这表明结合配体可能通过调节 CXCR4 的寡聚状态而不是通过简单地诱导构象变化来实现其关键作用。

相似文献

1
Single-Molecule Imaging Demonstrates Ligand Regulation of the Oligomeric Status of CXCR4 in Living Cells.单分子成像显示配体调节 CXCR4 寡聚状态在活细胞中。
J Phys Chem B. 2017 Feb 23;121(7):1466-1474. doi: 10.1021/acs.jpcb.6b10969. Epub 2017 Feb 9.
2
Single-molecule imaging reveals dimerization/oligomerization of CXCR4 on plasma membrane closely related to its function.单分子成像揭示了 CXCR4 在质膜上的二聚化/寡聚化与其功能密切相关。
Sci Rep. 2017 Dec 4;7(1):16873. doi: 10.1038/s41598-017-16802-7.
3
Chemokine receptor CXCR4 oligomerization is disrupted selectively by the antagonist ligand IT1t.趋化因子受体CXCR4的寡聚化被拮抗剂配体IT1t选择性破坏。
J Biol Chem. 2021 Jan-Jun;296:100139. doi: 10.1074/jbc.RA120.016612. Epub 2020 Dec 6.
4
Advanced fluorescence microscopy reveals disruption of dynamic CXCR4 dimerization by subpocket-specific inverse agonists.高级荧光显微镜揭示了亚口袋特异性反向激动剂对 CXCR4 二聚化的动态破坏。
Proc Natl Acad Sci U S A. 2020 Nov 17;117(46):29144-29154. doi: 10.1073/pnas.2013319117. Epub 2020 Nov 4.
5
Dimerization of CXCR4 in living malignant cells: control of cell migration by a synthetic peptide that reduces homologous CXCR4 interactions.活恶性细胞中CXCR4的二聚化:一种减少同源CXCR4相互作用的合成肽对细胞迁移的控制。
Mol Cancer Ther. 2006 Oct;5(10):2474-83. doi: 10.1158/1535-7163.MCT-05-0261.
6
The Epstein-Barr virus-encoded G protein-coupled receptor BILF1 hetero-oligomerizes with human CXCR4, scavenges Gαi proteins, and constitutively impairs CXCR4 functioning.EB 病毒编码的 G 蛋白偶联受体 BILF1 与人类 CXCR4 形成异源寡聚体,消耗 Gαi 蛋白,并持续损害 CXCR4 的功能。
J Biol Chem. 2010 Sep 17;285(38):29632-41. doi: 10.1074/jbc.M110.115618. Epub 2010 Jul 9.
7
Structural basis for chemokine recognition by a G protein-coupled receptor and implications for receptor activation.G蛋白偶联受体识别趋化因子的结构基础及其对受体激活的影响
Sci Signal. 2017 Mar 21;10(471):eaah5756. doi: 10.1126/scisignal.aah5756.
8
Fluorescence resonance energy transfer imaging reveals that chemokine-binding modulates heterodimers of CXCR4 and CCR5 receptors.荧光共振能量转移成像显示趋化因子结合可调节CXCR4和CCR5受体的异二聚体。
PLoS One. 2008;3(10):e3424. doi: 10.1371/journal.pone.0003424. Epub 2008 Oct 16.
9
Ligand-independent higher-order multimerization of CXCR4, a G-protein-coupled chemokine receptor involved in targeted metastasis.CXCR4(一种参与靶向转移的G蛋白偶联趋化因子受体)的非配体依赖性高阶多聚化
Cancer Sci. 2009 Jan;100(1):95-102. doi: 10.1111/j.1349-7006.2008.00997.x. Epub 2008 Oct 30.
10
NeoR6 inhibits HIV-1-CXCR4 interaction without affecting CXCL12 chemotaxis activity.NeoR6抑制HIV-1与CXCR4的相互作用,而不影响CXCL12的趋化活性。
Biochim Biophys Acta. 2008 Jun;1780(6):914-20. doi: 10.1016/j.bbagen.2008.03.011. Epub 2008 Mar 21.

引用本文的文献

1
CXCL12 restricts tumor growth by suppressing the Ras, ERK1/2, c-Myc, and the immune checkpoint PD-L1 pathways.趋化因子CXCL12通过抑制Ras、ERK1/2、c-Myc以及免疫检查点PD-L1信号通路来限制肿瘤生长。
Proc Natl Acad Sci U S A. 2024 Dec 24;121(52):e2416909121. doi: 10.1073/pnas.2416909121. Epub 2024 Dec 17.
2
Structural insights into CXCR4 modulation and oligomerization.对CXCR4调节和寡聚化的结构见解。
Nat Struct Mol Biol. 2025 Feb;32(2):315-325. doi: 10.1038/s41594-024-01397-1. Epub 2024 Sep 23.
3
Multiple mechanisms of self-association of chemokine receptors CXCR4 and CCR5 demonstrated by deep mutagenesis.
深度诱变揭示趋化因子受体CXCR4和CCR5自我缔合的多种机制
bioRxiv. 2023 Mar 25:2023.03.25.534231. doi: 10.1101/2023.03.25.534231.
4
Targeting CXCR4 and CD47 Receptors: An Overview of New and Old Molecules for a Biological Personalized Anticancer Therapy.靶向 CXCR4 和 CD47 受体:生物个体化抗癌治疗的新老分子概述。
Int J Mol Sci. 2022 Oct 18;23(20):12499. doi: 10.3390/ijms232012499.
5
Sphingomyelin Depletion Inhibits CXCR4 Dynamics and CXCL12-Mediated Directed Cell Migration in Human T Cells.鞘磷脂耗竭抑制人 T 细胞中 CXCR4 动力学和 CXCL12 介导的定向细胞迁移。
Front Immunol. 2022 Jul 12;13:925559. doi: 10.3389/fimmu.2022.925559. eCollection 2022.
6
Chemokine receptor CXCR4 oligomerization is disrupted selectively by the antagonist ligand IT1t.趋化因子受体CXCR4的寡聚化被拮抗剂配体IT1t选择性破坏。
J Biol Chem. 2021 Jan-Jun;296:100139. doi: 10.1074/jbc.RA120.016612. Epub 2020 Dec 6.
7
Single-molecule microscopy for in-cell quantification of protein oligomeric stoichiometry.单分子显微镜用于细胞内蛋白质寡聚化计量比的定量分析。
Curr Opin Struct Biol. 2021 Feb;66:112-118. doi: 10.1016/j.sbi.2020.10.022. Epub 2020 Nov 23.
8
Advanced fluorescence microscopy reveals disruption of dynamic CXCR4 dimerization by subpocket-specific inverse agonists.高级荧光显微镜揭示了亚口袋特异性反向激动剂对 CXCR4 二聚化的动态破坏。
Proc Natl Acad Sci U S A. 2020 Nov 17;117(46):29144-29154. doi: 10.1073/pnas.2013319117. Epub 2020 Nov 4.
9
At the Bench: Pre-clinical evidence for multiple functions of CXCR4 in cancer.在实验台上:CXCR4 在癌症中的多种功能的临床前证据。
J Leukoc Biol. 2021 May;109(5):969-989. doi: 10.1002/JLB.2BT1018-715RR. Epub 2020 Oct 26.
10
Probing the Druggablility on the Interface of the Protein-Protein Interaction and Its Allosteric Regulation Mechanism on the Drug Screening for the CXCR4 Homodimer.探索蛋白质-蛋白质相互作用界面上的可成药性及其对CXCR4同源二聚体药物筛选的变构调节机制。
Front Pharmacol. 2019 Nov 7;10:1310. doi: 10.3389/fphar.2019.01310. eCollection 2019.